- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04298125
Community Translation of the Expecting Study
September 29, 2025 updated by: Arkansas Children's Hospital Research Institute
Antenatal Factors Impacting Obesity and Metabolism in Children: Sub-objective 2D
The Expecting intervention as delivered in prior studies in a clinical setting is described in a previous approved IRB submission (Protocol 202954).
The current project will seek to engage community stakeholders to translate Expecting to a community-delivered intervention and to test its acceptability, feasibility, and fidelity in a proof of principle study with 60 expecting mothers.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to adapt and determine acceptability, feasibility and fidelity of the research- clinic-based Expecting intervention with pregnant women with obesity in community settings.
Specifically, the investigators will show effective application of the Replicating Effective Programs (REP) framework (e.g., fidelity, feasibility, acceptability) to translate the research clinic-based intervention to community settings.
REP provides a four-phase process for implementing evidence-based interventions and has demonstrated effective application to translate clinical interventions to community settings.
Built into the REP framework is the collection of feedback from community stakeholders, iterative piloting of the intervention in the community, and a process for standardizing the intervention across community settings.
Following adaptation, the updated intervention will be piloted.
The pilot study will include 60 expecting women.
The investigators will randomize half to receive the community-adapted Expecting intervention (Intervention, N=30) and half to receive standard of care (Control, N=30).
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Taren Swindle, PhD
- Phone Number: 501-526-7058
- Email: tswindle@uams.edu
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Recruiting
- Arkansas Children's Nutrition Center
-
Contact:
- Taren M Swindle, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- (a) Body Mass Index > 30,
- (b) singleton pregnancy,
- (c) between 11-15 weeks of pregnancy (at enrollment),
- (d) Do not currently meet recommended guidelines of 150 min of activity per week
- (e) cleared by physician
Exclusion Criteria:
- (a) contraindications for exercise (preeclampsia-eclampsia, premature rupture of the membranes, antepartum hemorrhage, placenta previa, multiple gestation and other defined conditions)
- (b) illicit drug use.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise in Pregnancy in Community
The Expecting intervention at the ACNC includes three 30-45 minute, in-person exercise sessions per week.
The sessions are gradually increased in length over the first weeks of participation, and are comprised of 15-30 minutes of moderate aerobic activity (recumbent bike, walking on a treadmill or on an elliptical machine) as well as 5-10 minutes of resistance training using hydraulic exercise equipment.
The sessions conclude with stretching exercises.
Throughout the session, a personal trainer assesses the rating of perceived exertion using the 6 to 20 point Borg scale of exhaustion.41 Between sessions, participants are asked to monitor their daily step count with a target of 10,000 steps per day using a pedometer provided to the participant.
This number is reported to or downloaded by the personal trainer at each in-person session.
These elements will be adapted to provide a similar exercise experience that is accessible to women in their local community.
|
Women in this group will participate in psychical activity 3 times per week in their community setting.
|
|
No Intervention: Standard Care
Participants will receive guidance on exercise from their physician as usual.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Intervention Measure:38 weeks
Time Frame: 38 weeks
|
Attitudinal Implementation Outcome on a 1 to 5 scale
|
38 weeks
|
|
Acceptability of Intervention Measure: 38 weeks
Time Frame: 38 weeks
|
Attitudinal Implementation Outcome on a 1 to 5 scale
|
38 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of intervention sessions completed
Time Frame: 15 weeks through 38 weeks
|
Measured with attendance records
|
15 weeks through 38 weeks
|
|
Number of minutes of physical activity
Time Frame: Change from Baseline to Delivery and 6 Months Post Delivery
|
Measured with Actical
|
Change from Baseline to Delivery and 6 Months Post Delivery
|
|
Body Mass Index
Time Frame: Change from Baseline to Delivery and 6 Months Post Delivery
|
Collected from Medical Record, weight and height will be combined to report BMI in kg/m^2
|
Change from Baseline to Delivery and 6 Months Post Delivery
|
|
Blood Pressure
Time Frame: Change from Baseline to Delivery and 6 Months Post Delivery
|
Collected from Medical Record
|
Change from Baseline to Delivery and 6 Months Post Delivery
|
|
Total Cholesterol from Lipid Panel
Time Frame: Change from Baseline to Delivery and 6 Months Post Delivery
|
Collected from Medical Record
|
Change from Baseline to Delivery and 6 Months Post Delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 16, 2021
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Study Registration Dates
First Submitted
February 17, 2020
First Submitted That Met QC Criteria
March 5, 2020
First Posted (Actual)
March 6, 2020
Study Record Updates
Last Update Posted (Estimated)
October 2, 2025
Last Update Submitted That Met QC Criteria
September 29, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 260132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
The University of Texas Health Science Center at...The University of Texas at San AntonioCompleted
-
Gynuity Health ProjectsCuidado Integral de la Mujer, Gineclinic, S.C.; Servicios de Salud Medieg,...Not yet recruitingPregnancy Related | Pregnancy Early
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
Portucalense UniversityAveiro University; Unidade Local de Saúde do Alto Ave, EPERecruiting
-
Oregon Health and Science UniversityNot yet recruitingPregnancy Related
-
Oregon Health and Science UniversityRecruiting
-
Biorithm Pte LtdNot yet recruitingPregnancy Related
Clinical Trials on Exercise in Pregnancy
-
Federico II UniversityRecruiting
-
Cwm Taf University Health Board (NHS)Cardiff University; Swansea University; Cardiff Metropolitan University; Burdett... and other collaboratorsActive, not recruiting
-
Hospital do Servidor Publico EstadualMaternal Breastfeeding Incentive Center (CIAMA)Completed
-
Kastamonu UniversityCompletedLow Back Pain | Pregnancy Related | Nurse's RoleTurkey
-
Region Örebro CountyUnknown
-
Unity Health TorontoCompletedPregnancy | HIV | AIDS VirusCanada
-
Universiti Putra MalaysiaCompleted
-
Habil HamdouniFaculty of Medicine, SousseCompletedLumbopelvic Range of Motion in Second-Trimester PregnancyTunisia
-
University of GlasgowScottish Collaboration for Public Health Research and PolicyCompletedPregnancy | Mental Health Wellness 1 | Mother-Child RelationsUnited Kingdom
-
Ottawa Hospital Research InstituteChildren's Hospital of Eastern Ontario Research Institute; Kingston Health...CompletedMarijuana Use | Cannabis UseCanada